Thompson Siegel & Walmsley LLC Organon & Co. Transaction History

Thompson Siegel & Walmsley LLC

$6.71 Billion
Q3 2024

A detailed history of Thompson Siegel & Walmsley LLC transactions in Organon & Co. stock. As of the latest transaction made, Thompson Siegel & Walmsley LLC holds 2,262,379 shares of OGN stock, worth $33.3 Million. This represents 0.64% of its overall portfolio holdings.

Number of Shares

2,262,379

Previous 2,125,922 6.42%

Holding current value

$33.3 Million

Previous $44 Million 1.65%

% of portfolio

0.64%

Previous 0.7%

14 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 12, 2024	BUY	$18.65 - $23.03 $2.54 Million - $3.14 Million	136,457 Added 6.42%	2,262,379 $43.3 Million
Q2 2024 Aug 08, 2024	BUY	$17.45 - $21.96 $1.22 Million - $1.53 Million	69,843 Added 3.4%	2,125,922 $44 Million
Q1 2024 May 09, 2024	SELL	$13.78 - $18.8 $2.77 Million - $3.78 Million	-201,231 Reduced 8.91%	2,056,079 $38.7 Million
Q4 2023 Feb 07, 2024	BUY	$10.95 - $17.32 $7.78 Million - $12.3 Million	710,420 Added 45.93%	2,257,310 $32.6 Million
Q3 2023 Nov 08, 2023	BUY	$16.59 - $23.77 $5.63 Million - $8.06 Million	339,210 Added 28.09%	1,546,890 $26.9 Million
Q2 2023 Aug 10, 2023	BUY	$19.27 - $24.63 $909,062 - $1.16 Million	47,175 Added 4.07%	1,207,680 $25.1 Million
Q1 2023 May 11, 2023	BUY	$21.42 - $32.08 $9.33 Million - $14 Million	435,487 Added 60.07%	1,160,505 $27.3 Million
Q4 2022 Feb 10, 2023	BUY	$23.31 - $28.61 $16.9 Million - $20.7 Million	725,018 New	725,018 $20.3 Million
Q3 2022 Oct 25, 2022	SELL	$23.4 - $34.25 $1.79 Million - $2.61 Million	-76,306 Reduced 5.12%	1,414,985 $33.1 Million
Q2 2022 Jul 22, 2022	SELL	$31.66 - $38.9 $14.1 Million - $17.4 Million	-446,075 Reduced 23.02%	1,491,291 $50.3 Million
Q1 2022 Apr 26, 2022	SELL	$30.45 - $39.36 $29.8 Million - $38.5 Million	-977,141 Reduced 33.53%	1,937,366 $67.7 Million
Q4 2021 Feb 09, 2022	BUY	$28.67 - $37.13 $10.5 Million - $13.6 Million	367,113 Added 14.41%	2,914,507 $88.7 Million
Q3 2021 Nov 05, 2021	SELL	$28.63 - $35.64 $2.49 Million - $3.1 Million	-86,912 Reduced 3.3%	2,547,394 $83.5 Million
Q2 2021 Aug 09, 2021	BUY	$28.45 - $38.0 $74.9 Million - $100 Million	2,634,306 New	2,634,306 $79.7 Million

Others Institutions Holding OGN

# of Institutions

793

Shares Held

192M

Call Options Held

1.71M

Put Options Held

865K

View Full List

About Organon & Co.

Ticker OGN
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 254,330,000
Market Cap $3.74B
Description
Organon & Co., a health care company, develops and delivers health solutions through a portfolio of prescription therapies in the United States and internationally. Its women's health portfolio comprises contraception and fertility brands, such as Nexplanon/Implanon, a long-acting reversible contraceptive. The company's biosimilars portfolio...

More about OGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Thompson Siegel & Walmsley LLC, based on Form 13F filings with the SEC.

News

Stay updated on Thompson Siegel & Walmsley LLC with notifications on news.

Account

Thompson Siegel & Walmsley LLC Organon & Co. Transaction History